OR WAIT null SECS
June 20, 2024
The companies have completed the expansion and qualification phase and now enter a stand-by phase for five years.
June 19, 2024
The $58 million investment has resulted in a 72,000-square-foot facility with a dedicated LC–MS space and molecular suites and will bring as many as 350 new jobs onto the campus.
June 14, 2024
Ecolab Life Sciences and Repligen have launched a new affinity resin, DurA Cycle, for large-scale biologics manufacturing.
June 13, 2024
Syngene's new production platform offers rapid protein synthesis with lower risk.
June 12, 2024
CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.
The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.
June 11, 2024
Syntegon will expand its processing and packaging by acquiring the Spanish equipment supplier.
June 07, 2024
Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.
Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs.
June 06, 2024
Lars Petersen, CEO, FUJIFILM Diosynth Biotechnologies discusses the company’s strategic goals and meeting market demand for mammalian cell culture capacity.